West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 177,800 | 121,500 | 55,400 | 206,900 | 154,900 |
| Depreciation Amortization | 77,100 | 51,800 | 25,500 | 104,400 | 78,100 |
| Income taxes - deferred | N/A | N/A | N/A | 900 | N/A |
| Accounts receivable | N/A | N/A | N/A | -43,800 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 400 | N/A |
| Other Working Capital | -16,300 | -34,100 | -38,800 | -28,300 | -32,600 |
| Other Operating Activity | 22,200 | 13,500 | 5,500 | 48,100 | 15,000 |
| Operating Cash Flow | $260,800 | $152,700 | $47,600 | $288,600 | $215,400 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -88,800 | -57,100 | -28,800 | -104,700 | -74,700 |
| Net Acquisitions | -18,900 | -18,900 | N/A | N/A | N/A |
| Other Investing Activity | 300 | 200 | 100 | 3,900 | 2,500 |
| Investing Cash Flow | $-107,400 | $-75,800 | $-28,700 | $-100,800 | $-72,200 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 28,000 | 28,000 | 28,000 | N/A | N/A |
| Debt Repayment | 0 | 0 | -28,000 | -100 | 0 |
| Common Stock Issued | 29,500 | 18,800 | 4,500 | 32,300 | 29,300 |
| Common Stock Repurchased | -83,100 | -83,100 | -83,100 | -70,800 | -70,800 |
| Dividend Paid | -33,300 | -22,200 | -11,100 | -42,100 | -31,000 |
| Other Financing Activity | -28,900 | -28,900 | -800 | 0 | 0 |
| Financing Cash Flow | $-87,800 | $-87,400 | $-90,500 | $-80,700 | $-72,500 |
| Exchange Rate Effect | -7,000 | -200 | -300 | -5,600 | -9,300 |
| Beginning Cash Position | 337,400 | 337,400 | 337,400 | 235,900 | 235,900 |
| End Cash Position | 396,000 | 326,700 | 265,500 | 337,400 | 297,300 |
| Net Cash Flow | $58,600 | $-10,700 | $-71,900 | $101,500 | $61,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 260,800 | 152,700 | 47,600 | 288,600 | 215,400 |
| Capital Expenditure | -88,800 | -57,100 | -28,800 | -104,700 | -74,700 |
| Free Cash Flow | 172,000 | 95,600 | 18,800 | 183,900 | 140,700 |